Clinical trial
A Phase 1/2 Randomized, Active- Controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of COVIVAC Vaccine Produced by IVAC in Adults ≥ 18 and ≥ 60 Years Old in Vietnam
NCT05940194 is registered in ClinicalTrials.gov with Institute of Vaccines and Medical Biologicals, Vietnam as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Randomized, Active- Controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of COVIVAC Vaccine Produced by IVAC in Adults ≥ 18 and ≥ 60 Years Old in Vietnam
- Lead sponsor
- Institute of Vaccines and Medical Biologicals, Vietnam
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 11, 2021
- Completion date
- March 11, 2022
- Enrollment
- 374 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.